Search
SOLACI Congress
Presentations

ASOCIACION DE DROGAS O DROGA UNICA en HTA

solaci
solaci
4
0
19_jose_ortellado

Por: Dr. Jose Ortellado
Egresado UC
Presidente de la SPMI
Director del PNPC-MSPYBS
FACP
Docente UCV-UCA

Previous article
Trombosis muy tardía de Stent por Angiografía. Un Caso de Progresión de la Aterosclerosis por OCT
Next article
OBJETIVOS TERAPEUTICOS DE LA PRESION ARTERIAL EN LAS COMORBILIDADES
solaci
solaci

More articles by this author

Recambio valvular aórtico tradicional: PARTNER 5 anos

solaci - 0
By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil

Estenosis aórtica severa con bajo flujo, bajo gradiente y disfunción sistólica

solaci - 0
By: Rubén G. Servián C. MD Departamento de Imágenes – Hospital Central Instituto de Previsión Social (I.P.S.)

Prevención de la enfermedad cardiovascular y ejercicio físico en el adulto: ¿ una cuestión de intensidad?

solaci - 0
By: Dra. María Carolina Acosta Cazal

Angioplastía en Tronco coronario izquierdo y Enfermedad de Múltiples Vasos. Nuevas evidencias 2015.

solaci - 0
By: Dr. Marcelo Halac Hospital Italiano - Buenos Aires

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Presentations

Recambio valvular aórtico tradicional: PARTNER 5 anos

By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil
solaci -
SOLACI Sessionsspot_img

Recent Articles

Evolution of Small Balloon-Expandable Valves

Dr. Carlos Fava - 0
Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

solaci - 0
Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Evolution of Small Balloon-Expandable Valves

Dr. Carlos Fava - 0
Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

solaci - 0
Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

Institutional News

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

solaci - 0
The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy